Leukemia: all 5,475 studies
Page 37 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia PatientsStatus unknownNCT01633099Phase 3
- A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in RemissionCompletedNCT01632852Phase 1
- Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 TrialCompletedNCT01629745
- Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid LeukemiaCompletedNCT01629082Phase 1
- Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop TrialStatus unknownNCT01627132Phase 2
- A Phase II Study of AT7519M, a CDK Inhibitor, in Patients With Relapsed and/or Refractory Chronic Lymphocytic LeukemiaCompletedNCT01627054Phase 2
- Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic LeukemiaCompletedNCT01626183
- Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction ImmunochemotherapyTerminatedNCT01625741Phase 2
- Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic LeukemiaCompletedNCT01625143
- Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor CellsTerminatedNCT01624701Phase 1/2
- WT1 TCR Gene Therapy for Leukaemia: A Phase I/II Safety and Toxicity StudyCompletedNCT01621724Phase 1/2
- NK Cells in Cord Blood TransplantationStatus unknownNCT01619761Phase 1
- Osteonecroses in Pediatric Patients With ALLStatus unknownNCT01619124
- Randomized Trial of Mobilized Blood/Marrow Versus Blood TransplantWithdrawnNCT01617473Not applicable
- Randomised Study of Azacitidine Versus Azacitidine With Vorinostat in Patients With AML or High Risk MDSCompletedNCT01617226Phase 2
- A Study for Older Adults With Acute Lymphoblastic LeukaemiaCompletedNCT01616238Phase 2
- Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL PilotTerminatedNCT01615146Not applicable
- Phase I Study of Lenalidomide in Patients With Acute LeukemiaTerminatedNCT01615042Phase 1
- A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) PatientsCompletedNCT01613976Phase 1
- Treatment With Bendamustine, Ofatumumab and MethylPrednisolone in Relapsed B-CLLTerminatedNCT01612988Phase 2
- Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic LeukemiaCompletedNCT01611116Phase 2
- Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant SurvivorsActive, not recruitingNCT01608152
- Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid MalignanciesCompletedNCT01606579Phase 1/2
- Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKICompletedNCT01602952Phase 1/2
- Effect of Oral Supplementation With a Fibre Enriched Paediatric Sip Feed For Children With Acute Lymphocytic LeukemiaCompletedNCT01600781Not applicable
- Trial of Haploidentical Stem Cell Transplantation for Haematological CancersCompletedNCT01597219Phase 2
- European Stop Tyrosine Kinase Inhibitor StudyCompletedNCT01596114Phase 3
- Registry on Hypomethylating Agents in Myeloid NeoplasmsCompletedNCT01595295
- Liposomal Cytarabine in the Treatment of Central Nervous System Resistant or Relapsed Acute Lymphoblastic Leukemia in ChildrenStatus unknownNCT01593488Phase 2
- Expanded Access Program of PonatinibApproved for marketingNCT01592136
- Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell TransplantCompletedNCT01588015Phase 1
- 3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid LeukemiaStatus unknownNCT01587430Phase 4
- Human Placental-Derived Stem Cell TransplantationCompletedNCT01586455Phase 1
- Phase I/II Study of hLL1-DOX in Relapsed NHL and CLLTerminatedNCT01585688Phase 1/2
- Studying Samples From Patients With T-Cell Acute Lymphoblastic LeukemiaCompletedNCT01581528
- A Phase 3 Study Comparing Dinaciclib Versus Ofatumumab in Patients With Refractory Chronic Lymphocytic Leukemia (P07714)CompletedNCT01580228Phase 3
- Lenalidomide as Consolidation and Maintenance in Adults >/= 60 Years of Age With AML Following Standard InductionCompletedNCT01578954Phase 1
- Sorafenib Tosylate Before and After Donor Bone Marrow Transplant in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01578109Phase 1
- Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid LeukemiaCompletedNCT01576185
- S0106B Studying Bone Marrow Samples From Women With Acute Myeloid LeukemiaCompletedNCT01575535
- Safety Study of AKN-028 in Patients With Acute Myelogenous LeukemiaTerminatedNCT01573247Phase 1/2
- Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaCompletedNCT01567709Phase 1
- Tosedostat in Combination With Cytarabine or Decitabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeCompletedNCT01567059Phase 2
- Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters StudyCompletedNCT01565447
- Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantWithdrawnNCT01558778Not applicable
- A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic LeukemiaCompletedNCT01558167Phase 1/2
- Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)CompletedNCT01557777Phase 2
- Health Counseling and Exercise in Patients With Acute Leukemia - Pilot StudyCompletedNCT01557686Early Phase 1
- A Study of Lenalidomide Maintenance for High-risk Patients With CLL Following First-line TherapyCompletedNCT01556776Phase 3
- The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).Status unknownNCT01556477Phase 2
- Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic LeukemiaCompletedNCT01556386
- Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01555268Phase 1
- Lenalidomide and Dexamethasone in Primary Plasma Cell LeukemiaCompletedNCT01553357Phase 2
- Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic LeukemiaCompletedNCT01553162
- A Pilot Study of Recombinant Human Arginase 1 (rhArg1) in Patients With Relapsed or Refractory Leukemia or LymphomaTerminatedNCT01551628Phase 1
- Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid LeukemiaTerminatedNCT01550185Phase 1
- Compassionate Use PonatinibNo longer availableNCT01549548
- Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid LeukemiaWithdrawnNCT01548911Phase 2
- TevaGastrim for Stem Cell Mobilization Sibling DonorsCompletedNCT01542944Phase 2
- Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTSCompletedNCT01540812
- Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic LeukemiaCompletedNCT01540578
- MRI Assessment of Leukemia Response to TherapyCompletedNCT01537159
- Nilotinib in PH+, BCR-, ABL+ CML PatientsCompletedNCT01535391Phase 3
- IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT01534715Phase 1
- Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AMLStatus unknownNCT01534702Phase 1/2
- Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic LeukemiaCompletedNCT01533168
- Evaluation of Efficacy and Safety of Nilotinib in Combination With Chemotherapy in Elderly Patients With Philadelphia Chromosome Positive Acute Lymphoblastic LeukemiaCompletedNCT01528085Phase 2
- Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood UnitCompletedNCT01527838Phase 1
- Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALLCompletedNCT01523977Phase 1
- Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid MalignanciesCompletedNCT01523223Phase 1
- Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction ChemotherapyTerminatedNCT01521936Phase 2
- Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation TreatmentStatus unknownNCT01521689Phase 2
- Targeted Radiotherapy in HSCT for Poor Risk Haematological MalignancyCompletedNCT01521611Phase 1/2
- Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic SyndromeWithdrawnNCT01520805Phase 2
- Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic LeukemiaCompletedNCT01520246
- Symptom-Adapted Physical Activity Intervention in Minimizing Physical Function Decline in Older Patients With Acute Myeloid Leukemia Undergoing ChemotherapyCompletedNCT01519596Not applicable
- Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral AzacitidineCompletedNCT01519011Phase 1
- Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid LeukemiaCompletedNCT01518556Phase 1/2
- Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After TransplantationTerminatedNCT01517347Not applicable
- Improving Blood Stem Cell Collection and Transplant ProceduresCompletedNCT01517035Phase 1/2
- Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic LeukemiaStatus unknownNCT01513603Phase 2
- Safety and Immunogenicity of Recombinant WT1 Antigen-Specific Cancer Immunotherapeutic Combined With Infusion of Treg Depleted T Cells for Adult WT1 Acute Myeloid LeukemiaStatus unknownNCT01513109Phase 1/2
- Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative DisorderCompletedNCT01511575
- Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase PatientsCompletedNCT01511289Phase 3
- HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid TumorsStatus unknownNCT01509300Phase 1/2
- Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid OverloadWithdrawnNCT01508260Not applicable
- Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical TrialCompletedNCT01507441
- Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic LeukemiaCompletedNCT01505699
- S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab OzogamicinCompletedNCT01503541
- A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous LeukemiaStatus unknownNCT01503502Phase 2
- Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01500499
- Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchTerminatedNCT01500161Phase 2
- Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid LeukemiaCompletedNCT01498302
- Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute LeukemiaStatus unknownNCT01498016Phase 2
- Infusion of Allogeneic CD19-Specific T Cells From Peripheral BloodCompletedNCT01497184Phase 1
- Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and VomitingWithdrawnNCT01492569Not applicable
- Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVEStatus unknownNCT01491763Phase 4
- Telemonitoring Study - for Chronic Myeloid Leukemia (CML)TerminatedNCT01490983Not applicable
- Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based TherapyCompletedNCT01490853
- Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) PatientsTerminatedNCT01489722Phase 1